Cargando…
The impact of obesity on the outcome of severe SARS-CoV-2 ARDS in a high volume ECMO centre: ECMO and corticosteroids support the obesity paradox
PURPOSE: The aim was to verify the impact of obesity on the long-term outcome of patients with severe SARS-CoV-2 ARDS. MATERIALS AND METHODS: The retrospective study included patients admitted to the high-volume ECMO centre between March 2020 and March 2022. The impact of body mass index (BMI), co-m...
Autores principales: | Balik, M., Svobodova, E., Porizka, M., Maly, M., Brestovansky, P., Volny, L., Brozek, T., Bartosova, T., Jurisinova, I., Mevaldova, Z., Misovic, O., Novotny, A., Horejsek, J., Otahal, M., Flaksa, M., Stach, Z., Rulisek, J., Trachta, P., Kolman, J., Sachl, R., Kunstyr, J., Kopecky, P., Romaniv, S., Huptych, M., Svarc, M., Hodkova, G., Fichtl, J., Mlejnsky, F., Grus, T., Belohlavek, J., Lips, M., Blaha, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547545/ https://www.ncbi.nlm.nih.gov/pubmed/36219946 http://dx.doi.org/10.1016/j.jcrc.2022.154162 |
Ejemplares similares
-
Pulmonary consolidation alters the ultrasound estimate of pleural fluid volume when considering chest drainage in patients on ECMO
por: Balik, Martin, et al.
Publicado: (2022) -
Morbidly obese with severe ARDS: ECMO or no ECMO?
por: Shalaby, Mohammed A.
Publicado: (2017) -
Efficacy and safety of 1C class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock compared to amiodarone: protocol of a prospective randomised double-blind study
por: Balik, Martin, et al.
Publicado: (2019) -
Coronavirus 2019 in a Morbidly Obese Patient: ECMO or No ECMO?
por: Shere, A., et al.
Publicado: (2022) -
Novel Methods for Predicting Fluid Responsiveness in Critically Ill Patients—A Narrative Review
por: Horejsek, Jan, et al.
Publicado: (2022)